5
Disclosures
Jan 30, 2026 — May 19, 2026
Date Range
STANDARD
Market Segment
Chemicals
Sector

Disclosures

DateTypeHeadlinePDF
May 19 Earnings Yuki Gosei Kogyo Sets Three-Year Business Plan for 2026-2028 PDF
Mar 19 Admin Yuki Gosei Kogyo: Appoints New Directors and Executive Officers PDF
Feb 26 Other Yuki Gosei Kogyo to Collaborate with Hodogaya Chemical on Nucleic Acid Medicines PDF
Jan 30 Forecast FY2026/3 Full-Year Earnings Forecast Revision PDF
Jan 30 Earnings Yuki Gosei Kogyo Co., Ltd. Q3 FY2026 Earnings Presentation: Revenue of 3.65 billion, +8.2% YoY PDF

Disclosure Types

Earnings: 2 Admin: 1 Other: 1 Forecast: 1